By Puyaan Singh and Christy Santhosh Feb 4 (Reuters) - AbbVie forecast 2026 profit above Wall Street estimates on Wednesday ...

Billions of dollars in U.S. biosimilar erosion to AbbVie’s blockbuster immunology drug Humira is no match for its rising ...

AbbVie (ABBV) stock slides 7% as its former best seller Humira drives Q4 2025 beat not newer immunology drugs. Read more here ...

CVS Health Inc. CVS on Thursday said it is taking additional steps to lower prescription drug costs by expanding access to ...

AbbVie Inc. stays a Strong Buy after a Q4 2025 earnings beat led by HUMIRA, plus growth in immunology and neuroscience. Click ...

Feb 4 (Reuters) - AbbVie forecast 2026 profit above Wall Street estimates on Wednesday after posting a fourth-quarter results ...

Feb 5 () - CVS Health said on Thursday it would swap out Amgen and Eli Lilly's bone disease treatments for ​lower-cost ...

AbbVie (NYSE:ABBV) has agreed to acquire Capstan Therapeutics to expand its work in in vivo CAR-T cell therapy. The company ...

The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and ...

The government website is meant to connect Americans with drug companies to buy prescriptions directly with their own money.

The Trump administration’s new website to help consumers find cheaper drugs is a worthy objective, but it comes with ...

WASHINGTON, Feb. 6 -- President Donald Trump on Thursday unveiled a government-backed online platform, TrumpRx.gov, designed ...